Bhutani T, Jayade S, Rege S, Penton H, Patel V, Kalirai S, Wolin D, Boyle K, Seigel L. Evaluating prevalence and consequence of residual disease in individuals with psoriasis receiving apremilast treatment: results from a US patient survey. J Dermatolog Trea. 2024 Jun 24;35(1):2366532. doi: 10.1080/09546634.2024.2366532
Myers K, Silverberg JI, Parasuraman S, Pierce A, Eichenfield LF, Poulos C. Treatment preferences among patients with mild-to-moderate atopic dermatitis. J Dermatolog Trea. 2023 Dec;34(1):2215356. doi: 10.1080/09546634.2023.2215356.
Kwatra SG, Lio P, Weidinger S, Calimlim B, Ladizinski B, Vigna N, Botha W, Mansfield C. Patient preferences for atopic dermatitis treatments: a discrete choice experiment. J Dermatolog Trea. 2023 Dec 1;34(1):2222201. doi: 10.1080/09546634.2023.2222201
Jia X, Zhao Y, Carrico J, Brodtkorb T-H, Mendelsohn AM, Lowry S, Feldman S, Wu JJ, Armstrong AW. Cost-effectiveness of tildrakizumab for the treatment of moderate-to-severe psoriasis in the United States. J Dermatolog Trea. 2022 Mar;33(2):740-8. doi: 10.1080/09546634.2020.1773382
Ervin C, Crawford R, Evans E, Feldman SR, Zeichner J, Zielinski M, Cappelleri JC, DiBonaventura M, Takiya L, Myers DE. Patient and caregiver preferences on treatment attributes for atopic dermatitis. J Dermatolog Trea. 2021 Oct 6;1-9. doi: 10.1080/09546634.2021.1940810
Feldman SR, Poulos C, Gilloteau I, Mange B, Boehm K, Boeri M, Naatz M, Augustin M. Exploring determinants of psoriasis patients' treatment choices: a discrete-choice experiment study in the United States and Germany. J Dermatolog Trea. 2021 Feb 3;1-10. doi: 10.1080/09546634.2020.1839007
Martin SA, Brown TM, Fehnel S, Deal LS, Katz EG, Chiou CF. The atopic dermatitis itch scale: development of a new measure to assess pruritus in patients with atopic dermatitis. J Dermatolog Trea. 2020 Aug;31(5):484-30708. doi: 10.1080/09546634.2020.1713971
Wu JJ, Jia X, Zhao Y, Carrico J, Brodtkorb TH, Mendelsohn A, Lowry A, Feldman SR, Armstrong A. Comparative cost-effectiveness of tildrakizumab and other commonly used treatments for moderate-to-severe psoriasis. J Dermatolog Trea. 2020 Apr 1;1-8. doi: 10.1080/09546634.2019.1698700
Giner-Soriano M, Teixido C, Marsal JR, Diez O, Pera H, Vlacho B, Morros R, working group for the clinical trial IJG-KOH-2014. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for molluscum contagiosum treatment in children. J Dermatolog Trea. 2019 Dec;30(8):750-6. doi: 10.1080/09546634.2019.1573305
Elewski BE, Puig L, Mordin M, Gilloteau I, Sherif B, Fox T, Gnanasakthy A, Papavassilis C, Strober BE. Psoriasis patients with Psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75-89 response: results from two phase 3 studies of secukinumab. J Dermatolog Trea. 2017 Sep;28(6):492-9. doi: 10.1080/09546634.2017.1307464
Korman NJ, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Nyirady J, Williams N, Mordin M, Tyring S. Secukinumab provides better relief from the impact of psoriasis on daily activities and personal relationships than etanercept: results of two phase 3 placebo-controlled randomized clinical trials in moderate-to-severe psoriasis. J Dermatolog Trea. 2017 Aug;28(5):384-9.
Pariser D, Schenkel B, Carter C, Farahi K, Brown TM, Ellis CN. A multicenter, non-interventional study to evaluate patient-reported experiences of living with psoriasis. J Dermatolog Trea. 2016 Jan;27(1):19-26. doi: 10.3109/09546634.2015.1044492
Montserrat-Capdevila J, Godoy P, Marsal JR, Barbe-Illa F. Factors associated with influenza immunization in primary care health workers. Gac Sanit. 2015 Sep;29(5):383-6. doi: 10.1016/j.gaceta.2015.02.004
Soler-Gonzalez J, Marsal JR, Serna C, Real J, Cruz I, Lopez A. Poorer diabetes control among the immigrant population than among the autochthonous population. Gac Sanit. 2013 Jan;27(1):19-25. doi: 10.1016/j.gaceta.2011.12.015
Forns J, Julvez J, Garcia-Esteban R, Guxens M, Ferrer M, Grellier J, Vrijheid M, Sunyer J. Maternal intelligence-mental health and child neuropsychological development at age 14 months. Gac Sanit. 2012 Sep;26(5):397-404. doi: 10.1016/j.gaceta.2011.10.011
Ferrer C, Garcia-Esteban R, Mendez M, Romieu I, Torrent M, Sunyer J. Social determinants of dietary patterns during pregnancy. Gac Sanit. 2009 Jan;23(1):38-43. doi: 10.1016/j.gaceta.2008.05.004
Fortuny J, Silverman D, Malats N, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Dosemeci M, Kogevinas M. Use of analgesics and aspirin in a Spanish multicenter study. Gac Sanit. 2005 Jul;19(4):316-20. doi: 10.1157/13078041
Garcia-Albeniz X, Guerra-Gutierrez F, Ortega-Martinez R, Sanchez-Víllegas A, Martinez-Gonzalez MA. Tobacco consumption in university graduates. Gac Sanit. 2004 Mar;18(2):108-17.
Bonfill X, Roura P, Moreno C, Rivero E, Rué M. Cancer mortality in the counties of Catalonia, Spain (1983-1989). Gac Sanit. 1997 Feb;11(2):74-82.
Portella E, Rivero E, Carrillo E, Colom D, Murillo C, Murillo J. Influence of municipal registry errors on the identification of a sample. Gac Sanit. 1991;5(25):183-4.